Deep Brain Stimulation Battery Exhaustion during the COVID-19 Pandemic: Crisis within a Crisis
Open Access
- 25 September 2020
- journal article
- research article
- Published by The Korean Movement Disorder Society in Journal of Movement Disorders
- Vol. 13 (3), 218-222
- https://doi.org/10.14802/jmd.20073
Abstract
Objective The novel coronavirus disease (COVID-19) pandemic and public health measures to control it have resulted in unique challenges in the management of patients with deep brain stimulation (DBS). We report our experience with the management of acute worsening of symptoms due to battery exhaustion in 3 patients with DBS. Methods Patients with DBS for movement disorders who visited the emergency room due to battery exhaustion during the nationwide lockdown from April to May 2020 were included. Results Two patients with subthalamic nucleus-DBS for Parkinson's disease (PD) and one with globus pallidus interna-DBS for generalized dystonia presented with acute worsening of symptoms due to battery exhaustion. Urgent battery replacement was performed in both patients with PD. The patient with generalized dystonia was managed with medication adjustment as he chose to defer battery replacement. Conclusion DBS battery replacement can be an emergency Decisions regarding DBS battery replacement should be individualized during this COVID-19 pandemic.Keywords
This publication has 8 references indexed in Scilit:
- Recommendations for Deep Brain Stimulation Device Management During a PandemicJournal of Parkinson's Disease, 2020
- COVID-19: An Early Review of Its Global Impact and Considerations for Parkinson’s Disease Patient CareJournal of Movement Disorders, 2020
- Parkinson's Disease and COVID‐19: Perceptions and Implications in Patients and CaregiversMovement Disorders, 2020
- Impact of the COVID‐19 Pandemic on Parkinson's Disease and Movement DisordersMovement Disorders, 2020
- Movement Disorders in the World of COVID‐19Movement Disorders, 2020
- Malignant deep brain stimulator withdrawal syndromeBMJ Case Reports, 2019
- Anti-proliferative effects of mesenchymal stem cells (MSCs) derived from multiple sources on ovarian cancer cell lines: an in-vitro experimental studyJournal of Ovarian Research, 2019
- Life-threatening DBS withdrawal syndrome in Parkinson's disease can be treated with early reimplantationParkinsonism & Related Disorders, 2018